SAR 44.5
(-1.11%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 11.72 Million SAR | 41.37% |
2022 | 8.29 Million SAR | 15.65% |
2021 | 7.16 Million SAR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 2.25 Million SAR | -78.92% |
2024 Q2 | 2.25 Million SAR | 309.75% |
2023 Q3 | 2.7 Million SAR | -70.23% |
2023 FY | 11.72 Million SAR | 41.37% |
2023 Q1 | - SAR | -100.0% |
2023 Q2 | 9.1 Million SAR | 0.0% |
2023 Q4 | 10.69 Million SAR | 294.62% |
2022 Q4 | 7.62 Million SAR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 59.77 Million SAR | 80.391% |
Al-Dawaa Medical Services Company | 2.29 Billion SAR | 99.489% |
Nahdi Medical Company | 1.17 Billion SAR | 99.002% |
Almujtama Alraida Medical Co. | 168.88 Million SAR | 93.059% |